OPRX
Health Information Services · Healthcare
CEO, Board Member
2025-01-01–present
Equibles does not estimate personal net worth.
Get an email with a short summary when OptimizeRx Corp publishes a filing, an earnings call transcript or a press release.
Get OPRX alertsStephen Silvestro is recorded as CEO at OptimizeRx Corp (OPRX) since March 10, 2025 and Board Member at OptimizeRx Corp (OPRX) since January 1, 2025. The newest filing on record that lists Stephen Silvestro as Board Member at OptimizeRx Corp (OPRX) is dated April 30, 2026. OptimizeRx Corp reported in an 8-K filed June 12, 2026 that Stephen Silvestro was appointed director, effective June 9, 2026. OptimizeRx Corp reported in an 8-K filed March 10, 2025 that Stephen Silvestro was appointed Chief Executive Officer, effective March 10, 2025. OptimizeRx Corp reported in an 8-K filed December 23, 2024 that Stephen Silvestro was appointed interim CEO, effective December 31, 2024. The proxy statement of OptimizeRx Corp reports total compensation of $2,717,717 for Stephen Silvestro in fiscal 2025, including a base salary of $500,000. Disclosed compensation is on record for 8 fiscal years. Stephen Silvestro has spoken on 2 earnings calls across 1 company, most recently for OptimizeRx Corp on August 12, 2026. OptimizeRx Corp is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at OptimizeRx Corp includes William Febbo (CEO and Board Member), William J. Febbo (CEO and Board Member), Lynn O'Connor Vos (Chairman and Board Member) and 7 others.
“The following nominees were each elected to serve as director for a term that expires at the next annual meeting of shareholders and until his or her successor has been elected and qualified or until his or her earlier death, resignation or removal based upon the following votes:”
“On March 10, 2025, OptimizeRx Corporation (the “Company”) announced that Stephen Silvestro has been appointed to serve as the Company’s Chief Executive Officer, effective as of March 10, 2025 (the “Effective Date”).”
“We right now don't have any expectation baked into the back half for that large client coming back, but we are starting to see some progress around it that will definitely positively impact the back half. how much we're not really prepared to say at this point, but discussions are open and we're, you know, we're…”
“Thank you, Operator, and good afternoon to everyone joining us for today's first quarter 2026 earnings call. We delivered a solid start to the year, which exceeded consensus estimates on the top and bottom line.”
2025-03-10–present
2025-01-01–present
Last confirmed April 30, 2026
Proxy statement
OPRX
Health Information Services · Healthcare
CEO, Board Member
2025-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | OptimizeRx Corp (OPRX) | Chief Executive Officer | $500,000 | $2,717,717 |
| 2024 | OptimizeRx Corp (OPRX) | Chief Executive Officer | $400,000 | $973,132 |
| 2023 | OptimizeRx Corp (OPRX) | — | $384,583 | $970,357 |
| 2022 | OptimizeRx Corp (OPRX) | — | $350,000 | $1,558,637 |
| 2021 | OptimizeRx Corp (OPRX) | — | $330,000 | $1,243,902 |
| 2020 | OptimizeRx Corp (OPRX) | — | $300,000 | $866,190 |
| 2019 | OptimizeRx Corp (OPRX) | — | $188,821 | $1,120,199 |
| 2018 | OptimizeRx Corp (OPRX) | — | — | — |